Publication: A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations
Date
Date
Date
Citations
Hatz, C., Cramer, J. P., Vertruyen, A., Schwarz, T. F., von Sonnenburg, F., Borkowski, A., Lattanzi, M., Hilbert, A. K., Cioppa, G. D., & Leroux-Roels, G. (2012). A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. Vaccine, 30(32), 4820–4827. https://doi.org/10.1016/j.vaccine.2012.05.013
Abstract
Abstract
Abstract
BACKGROUND: Modern cell-culture production techniques and the use of adjuvants helps to ensure that the global demand for pandemic influenza vaccine can be met. This study aimed to assess the immunogenicty and safety profiles of various cell-culture-derived A/H1N1 pandemic vaccine formulations in healthy adult and elderly subjects. METHODS: Adult (18-60 years) subjects (n=544) received vaccine either containing 3.75 μg of antigen with half the standard dose of MF59 (Novartis Vaccines and Diagnostics) adjuvant, 7.5 μg antigen with a fu
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Citations
Hatz, C., Cramer, J. P., Vertruyen, A., Schwarz, T. F., von Sonnenburg, F., Borkowski, A., Lattanzi, M., Hilbert, A. K., Cioppa, G. D., & Leroux-Roels, G. (2012). A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. Vaccine, 30(32), 4820–4827. https://doi.org/10.1016/j.vaccine.2012.05.013